Source: International Congress 2018 – Upper airways morphology and diagnostics, and the challenges associated with mandibular advancement
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
k. ohtsuka (Tokyo, Japan), K. Fukunaga (Tokyo, Japan), R. Baba (Tokyo, Japan), M. Haraguchi (Tokyo, Japan), R. Shirahama (Kanagawa, Japan), H. Senoura (Tokyo, Japan), N. Miyao (Kanagawa, Japan), T. Betsuyaku (Tokyo, Japan). Late Breaking Abstract - The effectiveness of NAS therapy for the treatment of mild to moderate OSAS. 5366

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Daily physical activity in patients with severe asthma and the effect of anti-IL5 therapy. Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019 Late Breaking Abstract - Daily physical activity in patients with severe eosinophilic asthma and the effect of anti-IL5 therapy. Source: International Congress 2018 – New pharmacological strategies in airway diseases Year: 2018 Late Breaking Abstract - Patients with severe eosinophilic asthma benefit from the treatment with Anti-IL-5 Reslizumab – a real life study from Austria Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Late Breaking Abstract - The burden of intermittent oral corticosteroid use in asthma Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science Year: 2021 Late Breaking Abstract - Effectiveness of multimodal remote patient monitoring at CPAP initiation in Obstructive Sleep Apnea (OSA) with high cardiovascular risk: A randomized trial Source: International Congress 2017 – Risk factors: symptomatology and diagnostic approaches for obstructive sleep apnoea Year: 2017 Mild OSAS: Is CPAP therapy actually required for these patients? Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018 Late Breaking Abstract - Efficacy and safety of tezepelumab in adults with severe asthma: A randomized phase 2 study Source: International Congress 2017 – Late-breaking studies in asthma and COPD Year: 2017 Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study Source: International Congress 2019 – Clinical approach to asthma management Year: 2019 Treatment of non-sleepy OSA patients - what are the alternatives ? Source: Annual Congress 2010 - Practical Workshop: "Treatment of non-sleepy OSA patients" Year: 2010 Late Breaking Abstract - Effect of oxygen supplementation on sleep and nocturnal breathing in patients with chronic obstructive pulmonary disease travelling to high altitude: randomized trial Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD? Year: 2018 Late Breaking Abstract - Short-term and maintenance oral corticosteroid use for German patients with asthma Source: International Congress 2019 – Powerful cohort studies with/without lung function Year: 2019 Late Breaking Abstract - Adrenal function improvement after oral corticosteroid reduction in benralizumab-treated severe eosinophilic asthma: PONENTE maintenance phase Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Late Breaking Abstract - CPAP is effective in treating COVID-19 patients with Type 1 respiratory failure. Source: Virtual Congress 2020 – Nasal high flow and non-invasive ventilation in acute and chronic care Year: 2020 Late Breaking Abstract - Long-term safety & durability of mepolizumab in life-threatening/seriously debilitating severe eosinophilic asthma (SEA): COSMEX Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Late Breaking Abstract - Prolonged azithromycin maintenance treatment in patients with COPD, a follow-up of the COLUMBUS trial Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019 Late Breaking Abstract - Comparative real world effectiveness of triple therapy versus dual bronchodilation in frequently exacerbating patients with COPD Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Late Breaking Abstract - Severe pneumonia patients may could not benefit from antibiotic combination therapy and non-invasive ventilation(NIV), despite the advanced mode Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure Year: 2018 Late Breaking Abstract - Danirixin (GSK1325756) improves respiratory symptoms and health status in mild to moderate COPD – results of a 1 year first time in patient study Source: International Congress 2017 – Primary care management of respiratory symptoms, allergies, inhalers and adherence Year: 2017 Late Breaking Abstract - Risk of a severe exacerbation following higher reliever use: post-hoc analysis of SYGMA 1 in mild asthma Source: International Congress 2018 – Variant forms of asthma Year: 2018 Late Breaking Abstract - Cost effectiveness of as-needed budesonide/formoterol vs low-dose ICS maintenance therapy in mild asthma patients: A UK perspective Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness Year: 2019